Upregulation of thyroid transcription factor-1 and human leukocyte antigen class I in Hashimoto's disease providing a clinical evidence for possible triggering autoimmune reaction

European Journal of Endocrinology

Volumn 164, Issue 5, 2011, Pages 795-800

  Huang, Huibin ^a   Li, Xisheng ^a   Lin, Ling ^a   Shi, Yaxiong ^a   Lin, Xiahong ^a   Li, Liangyi ^a   Xu, Dongming ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 1; MESSENGER RNA; THYROID TRANSCRIPTION FACTOR 1; AUTOANTIBODY; HLA ANTIGEN; NUCLEAR PROTEIN; THYROID NUCLEAR FACTOR 1; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID ADENOMA; THYROID CELL; UPREGULATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOLECULAR PATHOLOGY; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; AGED; BIOSYNTHESIS; COMPARATIVE STUDY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; AUTOANTIBODIES; FEMALE; HASHIMOTO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 79955540746     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0960     Document Type: Article

References (30)

1. Longhi MS, Ma Y, Mieli-Vergani G & Vergani D. Aetiopathogenesis of autoimmune hepatitis. Journal of Autoimmunity 2010 34 7-14. (doi:10.1016/j.jaut. 2009.08.010)
2. van Endert P, Hassainya Y, Lindo V, Bach JM, Blancou P, Lemonnier F & Mallone R. HLA class I epitope discovery in type 1 diabetes. Annals of the New York Academy of Sciences 2006 1079 190-197. (doi:10.1196/annals.1375.030)
3. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PG & Gamble DR. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. New England Journal of Medicine 1985 313 353-360. (doi:10.1056/NEJM198508083130604)
4. Kohn LD, Napolitano G, Singer DS, Molteni M, Scorza R, Shimojo N, Kohno Y, Mozes E, Nakazato M, Ulianich L, Chung HK, Matoba H, Saunier B, Suzuki K, Schuppert F & Saji M. Graves' disease: a host defense mechanism gone awry. International Reviews of Immunology 2000 19 633-664. (doi:10. 3109/08830180009088516)
5. Singer DS, Mozes E, Kirshner S & Kohn LD. Role of MHC class I molecules in autoimmune disease. Critical Reviews in Immunology 1997 17 463-468. (Pubitemid 27527395)
6. Kohn LD, Giuliani C, Montani V, Napolitano G, Ohmori M, Ohta M, Saji M, Schuppert F, Shong MH, Suzuki K, Taniguchi SI, Yano K & Singer DS. Antireceptor immunity. In Thyroid Autoimmunity, pp 115-170. Eds D Raynor & BR Champion. Austin, TX: RG Landes Co., 1995.
7. Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RC, Doniach D & Bottazzo GF. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 1983 2 1111-1115. (doi:10.1016/S0140-6736(83)90628-1)
8. Simmonds MJ, Howson JM, Heward JM, Carr-Smith J, Franklyn JA, Todd JA & Gough SC. A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect. Human Molecular Genetics 2007 16 2149-2153. (doi:10.1093/hmg/ddm165)
9. Schuppert F, Hiller W, Weinland G, Hoang-Vu C, von zur Muhlen A & Kohn LD. Iodide, cytokines and TSH-receptor expression in Graves' disease. Experimental and Clinical Endocrinology and Diabetes 1996 104 (Suppl 4) 68-74.
10. Suzuki K, Lavaroni S, Mori A, Ohta M, Saito J, Pietrarelli M, Singer DS, Kimura S, Katoh R, Kawaoi A & Kohn LD. Autoregulation of thyroid-specific gene transcription by thyroglobulin. PNAS 1998 95 8251-8256. (doi:10.1073/pnas.95.14.8251)
11. Schuppert F, Ehrenthal D, Frilling A, Suzuki K, Napolitano G & Kohn LD. Increased major histocompatibility complex (MHC) expression in nontoxic goiters is associated with iodide depletion, enhanced ability of the follicular thyroglobulin to increase MHC gene expression, and thyroid autoantibodies. Journal of Clinical Endocrinology and Metabolism 2000 85 858-867. (doi:10.1210/jc.85.2.858)
12. Mozes E, Kohn LD, Hakim F & Singer DS. Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. Science 1993 261 91-93. (doi:10.1126/science.8316860)
13. Singer DS, Kohn LD, Zinger H & Mozes E. Methimazole prevents induction of experimental systemic lupus erythematosus in mice. Journal of Immunology 1994 153 873-880. (Pubitemid 24206318)
14. Serreze DV, Leiter EH, Christianson GJ, Greiner D & Roopenian DC. Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 1994 43 505-509. (doi:10.2337/diabetes.43.3. 505)
15. Chan CC, Gery I, Kohn LD, Nussenblatt RB, Mozes E & Singer DS. Periocular inflammation in mice with experimental systemic lupus erythematosus. A new experimental blepharitis and its modulation. Journal of Immunology 1995 154 4830-4835.
16. Singer DS, Zinger H, Kohn LD & Mozes E. Differing MHC class I requirements for induction and propagation of experimental systemic lupus erythematosus. European Journal of Immunology 1999 29 2259-2268. (doi:10.1002/(SICI)1521-4141(199907) 29:07<2259::AID-IMMU2259>3.0.CO;2-1)
17. Wang P, Sun SH, Silver PB, Chan CC, Agarwal RK, Wiggert B, Kohn LD, Jamieson GA Jr & Caspi RR. Methimazole protects from experimental autoimmune uveitis (EAU) by inhibiting antigen presenting cell function and reducing antigen priming. Journal of Leukocyte Biology 2003 73 57-64. (doi:10.1189/jlb.0102047)
18. Mozes E, Lovchik J, Zinger H & Singer DS. MHC class I expression regulates susceptibility to spontaneous autoimmune disease in (NZBXNZW)F1 mice. Lupus 2005 14 308-314. (doi:10.1191/0961203305lu2079oa)
19. Saji M, Moriarty J, Ban T, Singer DS & Kohn LD. Major histocompatibility complex class I gene expression in rat thyroid cells is regulated by hormones, methimazole, and iodide as well as interferon. Journal of Clinical Endocrinology and Metabolism 1992 75 871-878. (doi:10.1210/jc.75.3. 871)
20. Schuppert F, Taniguchi S, Schroder S, Dralle H, von zur Muhlen A & Kohn LD. In vivo and in vitro evidence for iodide regulation of major histocompatibility complex class I and class II expression in Graves' disease. Journal of Clinical Endocrinology and Metabolism 1996 81 3622-3628. (doi:10.1210/jc.81.10.3622)
21. Mozes E, Zinger H, Kohn LD & Singer DS. Spontaneous autoimmune disease in (NZBXNZW)F1 mice is ameliorated by treatment with methimazole. Journal of Clinical Immunology 1998 18 106-113. (doi:10.1023/A:1023242732212)
22. Sheffield JB. ImageJ, a useful tool for biological image processing and analysis. Microscopy and Microanalysis 2007 13 200-201. (doi:10.1017/ S1431927607076611)
23. Saji M, Shong M, Napolitano G, Palmer LA, Taniguchi SI, Ohmori M, Ohta M, Suzuki K, Kirshner SL, Giuliani C, Singer DS & Kohn LD. Regulation of major histocompatibility complex class I gene expression in thyroid cells. Role of the cAMP response element-like sequence. Journal of Biological Chemistry 1997 272 20096-20107. (doi:10.1074/jbc.272.32.20096)
24. Lozanoska-Ochser B & Peakman M. Level of major histocompatibility complex class I expression on endothelium in non-obese diabetic mice influences CD8 T cell adhesion and migration. Clinical and Experimental Immunology 2009 157 119-127. (doi:10.1111/j.1365-2249.2009.03940.x)
25. Napolitano G, Montani V, Giuliani C, Di Vincenzo S, Bucci I, Todisco V, Laglia G, Coppa A, Singer DS, Nakazato M, Kohn LD, Colletta G & Monaco F. Transforming growth factor-b1 downregulation of major histocompatibility complex class I in thyrocytes: coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factors. Molecular Endocrinology 2000 14 486-505. (doi:10.1210/me.14.4.486)
26. Schuppert F, Deiters S, Rambusch E, Sierralta W, Dralle H & von zur Muhlen A. TSH-receptor expression and human thyroid disease: relation to clinical, endocrine, and molecular thyroid parameters. Thyroid 1996 6 575-587. (doi:10.1089/thy.1996.6.575)
27. Taniguchi SI, Shong M, Giuliani C, Napolitano G, Saji M, Montani V, Suzuki K, Singer DS & Kohn LD. Iodide suppression of major histocompatibility class I gene expression in thyroid cells involves enhancer A and the transcription factor NF-κB. Molecular Endocrinology 1998 12 19-33. (doi:10.1210/me.12.1.19)
28. Di Palma T, D'Andrea B, Liguori GL, Liguoro A, de Cristofaro T, Del Prete D, Pappalardo A, Mascia A & Zannini M. TAZ is a coactivator for Pax8 and TTF-1, two transcription factors involved in thyroid differentiation. Experimental Cell Research 2009 315 162-175. (doi:10.1016/j.yexcr.2008.10.016)
29. Altmann A, Schulz RB, Glensch G, Eskerski H, Zitzmann S, Eisenhut M & Haberkorn U. Effects of Pax8 and TTF-1 thyroid transcription factor gene transfer in hepatoma cells: imaging of functional protein-protein interaction and iodide uptake. Journal of Nuclear Medicine 2005 46 831-839.
30. Suzuki K, Mori A, Lavaroni S, Miyagi E, Ulianich L, Katoh R, Kawaoi A & Kohn LD. In vivo expression of thyroid transcription factor-1 RNA and its relation to thyroid function and follicular heterogeneity: identification of follicular thyroglobulin as a feedback suppressor of thyroid transcription factor-1 RNA levels and thyroglobulin synthesis. Thyroid 1999 9 319-331. (doi:10.1089/thy.1999.9.319)